Albert Bourla, Pfizer CEO (John Thys, Pool/AFP via Getty Images)
Pfizer loses closely watched court case on kickbacks and subsidizing drugs
A New York district court on Thursday knocked back Pfizer’s plan to subsidize the cost of one of its rare disease drugs for some Medicare …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
